GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Abnova Taiwan 4133.TW · TWD

Health Care · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

20.10

+2.81%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 351.3m

FY2016FY2025

Net income

−TWD 1.1m

FY2016FY2025

Free cash flow

−TWD 7.7m

FY2016FY2025

Shareholders' equity

TWD 1.26bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 351.3mTWD 355.3mTWD 382.1mTWD 411.8mTWD 451.5mTWD 456.4mTWD 414.2mTWD 426.0mTWD 475.1mTWD 439.8m
Gross profitTWD 139.9mTWD 163.3mTWD 173.9mTWD 201.4mTWD 197.3mTWD 213.5mTWD 185.3mTWD 185.4mTWD 228.9mTWD 206.7m
Research and developmentTWD 45.6mTWD 40.0mTWD 38.4mTWD 48.7mTWD 53.1mTWD 51.0mTWD 54.7mTWD 56.6mTWD 52.7mTWD 48.5m
Operating incomeTWD 17.1mTWD 34.3mTWD 47.2mTWD 95.8mTWD 37.7mTWD 53.2mTWD 28.6mTWD 21.6mTWD 59.0mTWD 48.5m
Net income−TWD 1.1mTWD 61.6mTWD 43.7mTWD 74.8mTWD 28.4mTWD 36.5mTWD 3.3mTWD 46.1mTWD 59.0mTWD 53.5m
Diluted earnings per share-0.020.990.721.240.480.610.060.750.980.88

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 1.33bnTWD 1.40bnTWD 1.36bnTWD 1.37bnTWD 1.28bnTWD 1.29bnTWD 1.26bnTWD 1.29bnTWD 1.30bnTWD 1.25bn
Cash and short-term investmentsTWD 378.7mTWD 448.5mTWD 423.5mTWD 367.9mTWD 307.3mTWD 258.3mTWD 167.8mTWD 145.6mTWD 188.1mTWD 231.8m
Total liabilitiesTWD 70.7mTWD 91.6mTWD 69.4mTWD 82.8mTWD 71.3mTWD 83.5mTWD 71.6mTWD 67.8mTWD 79.1mTWD 72.1m
DebtTWD 18.5mTWD 24.0mTWD 7.7mTWD 10.9mTWD 8.2mTWD 16.1mTWD 17.7mTWD 354,000TWD 736,000TWD 1.1m
Shareholders' equityTWD 1.26bnTWD 1.31bnTWD 1.29bnTWD 1.29bnTWD 1.21bnTWD 1.21bnTWD 1.19bnTWD 1.23bnTWD 1.22bnTWD 1.18bn
Shares outstanding61m62m61m61m60m60m54m62m60m61m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−TWD 4.2mTWD 50.9mTWD 76.2mTWD 132.4mTWD 92.9mTWD 105.3mTWD 74.5mTWD 89.2mTWD 67.5mTWD 71.9m
Capital spending−TWD 3.5m−TWD 7.7m−TWD 28.9m−TWD 13.9m−TWD 834,000−TWD 7.7m−TWD 13.3m−TWD 84.3m−TWD 88.0m−TWD 78.3m
Free cash flow−TWD 7.7mTWD 43.1mTWD 47.3mTWD 118.5mTWD 92.0mTWD 97.6mTWD 61.2mTWD 4.8m−TWD 20.4m−TWD 6.3m
Dividends paid−TWD 54.5m−TWD 43.6m−TWD 48.4m−TWD 27.9m−TWD 36.3m−TWD 6.1m−TWD 36.3m−TWD 48.4m−TWD 23.5m−TWD 11.1m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 88.3mTWD 87.9mTWD 83.9mTWD 85.3mTWD 91.6mTWD 90.5mTWD 88.0mTWD 90.4m
Gross profitTWD 41.2mTWD 42.1mTWD 35.2mTWD 37.0mTWD 39.8mTWD 39.8mTWD 38.4mTWD 41.6m
Operating incomeTWD 7.1mTWD 10.3mTWD 5.1mTWD 45,000TWD 4.2mTWD 6.6mTWD 3.5mTWD 8.3m
Net incomeTWD 6.2mTWD 16.7mTWD 10.5mTWD 11.5m−TWD 36.8mTWD 13.6mTWD 13.5mTWD 3.1m
Diluted earnings per share0.100.280.170.19-0.610.220.220.05
Cash from operationsTWD 12.0mTWD 22.0mTWD 12.0mTWD 3.0m−TWD 14.0m−TWD 5.0mTWD 6.0m−TWD 7.0m
Capital spending−TWD 2.0m—−TWD 1.0m−TWD 2.0m——−TWD 2.0m—
Free cash flowTWD 10.0m—TWD 11.0mTWD 1.0m——TWD 4.0m—
Total assetsTWD 1.35bnTWD 1.35bnTWD 1.33bnTWD 1.32bnTWD 1.38bnTWD 1.41bnTWD 1.40bnTWD 1.37bn
Cash and short-term investmentsTWD 406.2mTWD 395.8mTWD 378.7mTWD 367.8mTWD 423.0mTWD 440.3mTWD 448.5mTWD 446.0m
DebtTWD 5.6mTWD 5.6mTWD 5.2mTWD 5.3mTWD 5.4mTWD 5.5mTWD 5.5mTWD 2.5m
Shareholders' equityTWD 1.27bnTWD 1.27bnTWD 1.26bnTWD 1.24bnTWD 1.23bnTWD 1.27bnTWD 1.31bnTWD 1.30bn

Financial ratios

Data as of 2 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin39.8%46.0%45.5%48.9%43.7%46.8%
Operating margin4.9%20.7%12.8%23.1%8.4%11.7%
Net margin-0.3%17.3%11.4%18.2%6.3%8.0%
Return on equity-0.1%4.7%3.4%5.8%2.3%3.0%
Return on assets-0.1%4.4%3.2%5.4%2.2%2.8%
Free cash flow yield-0.1%4.7%8.6%12.0%7.8%9.4%
Revenue growth-1.1%-7.0%-7.2%-8.8%-1.1%10.2%
Earnings growth-101.9%41.0%-41.6%163.8%-22.3%1019.4%
Current ratio17.02x14.95x14.69x12.75x12.54x10.38x
Debt to equity0.00x0.00x0.00x0.01x0.01x0.01x
Equity ratio94.7%93.5%94.9%94.0%94.4%93.6%
Interest coverage40.21x622.98x344.35x625.71x153.42x193.41x
R&D as a share of sales13.0%11.3%10.0%11.8%11.8%11.2%
Buybacks as a share of market value2.9%-3.0%0.0%-1.6%0.3%-9.9%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-5.2%-5.1%-2.5%
Operating income-43.8%-20.3%-10.4%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin42.9%45.2%45.2%45.7%
Operating margin7.3%13.0%11.8%10.7%
Net margin8.6%11.9%10.1%9.8%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-1204.730.048.733.391.595.3423.540.140.040.8
Price to sales3.95.25.66.15.87.63.34.35.05.0

Dividends and splits

Per share, in the currency the company pays

Paid for 16 years. Last went ex-dividend on 16 Jun 2025.

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Paid in the year0.900.720.800.460.600.100.600.80
  • 1.03-for-1 split · 28 Aug 2017
  • 1.013-for-1 split · 26 Aug 2016

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.